Phase 3 Study of OTO-201 in Acute Otitis Externa

Status Completed

Clinical Trial Summary

This is a prospective, randomized, double-blind, sham-controlled, multicenter, Phase 3 study in which eligible subjects with acute otitis externa (AOE) will be randomized to receive a single administration of either 12 mg OTO-201 or Sham-Control (empty syringe) to the external auditory canal of the affected ear(s).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02801370
Study type	Interventional
Source	Otonomy, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	June 2016
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02918773` - Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)	N/A
Not yet recruiting	`NCT04636957` - A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)	Phase 3
Completed	`NCT01447017` - A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis	Phase 2
Completed	`NCT01535599` - Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa	Phase 3
Completed	`NCT00750633` - A Phase III Study of an Otic Formulation in Acute Otitis Externa	Phase 3
Terminated	`NCT00945802` - FST-201 In The Treatment of Acute Otitis Externa	Phase 3
Completed	`NCT03196973` - Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa	Phase 3
Recruiting	`NCT01584271` - Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)	Phase 2
Completed	`NCT02216071` - Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa	Phase 3
Completed	`NCT00961675` - FST-201 in the Treatment of Acute Otitis Externa	Phase 3
Completed	`NCT01535560` - Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa	Phase 3